Virtus ETF Advisers LLC Ab Cellera Biologics Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 27,678 shares of ABCL stock, worth $77,221. This represents 0.03% of its overall portfolio holdings.

Number of Shares

27,678

Previous 27,185 1.81%

Holding current value

$77,221

Previous $80,000 11.25%

% of portfolio

0.03%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.39 - $3.49 $1,178 - $1,720	493 Added 1.81%	27,678 $71,000
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $31,048 - $53,794	11,373 Added 71.93%	27,185 $80,000
Q1 2024 May 15, 2024	SELL	$4.29 - $5.97 $4,641 - $6,459	-1,082 Reduced 6.4%	15,812 $71,000
Q4 2023 Feb 15, 2024	BUY	$3.91 - $5.93 $13,720 - $20,808	3,509 Added 26.22%	16,894 $96,000
Q3 2023 Nov 07, 2023	SELL	$4.6 - $7.95 $6,113 - $10,565	-1,329 Reduced 9.03%	13,385 $61,000
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $26,777 - $35,908	4,731 Added 47.39%	14,714 $95,000
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $28,099 - $42,975	-3,844 Reduced 27.8%	9,983 $75,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $18,495 - $28,328	1,951 Added 16.43%	13,827 $140,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $846 - $1,258	92 Added 0.78%	11,876 $117,000
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $5,207 - $9,869	-698 Reduced 5.59%	11,784 $115,000
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $49,595 - $67,693	3,818 Added 44.07%	12,482 $178,000
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $6,637 - $9,538	-447 Reduced 4.91%	8,664 $174,000
Q2 2021 Aug 10, 2021	BUY	$20.19 - $34.17 $183,951 - $311,322	9,111 New	9,111 $200,000

Others Institutions Holding ABCL

# of Institutions

154

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $796M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Ab Cellera Biologics Inc. Transaction History